Sort By:

Products (24)

page of 2

Neuropilin-1 Antibodies

Neuropilin-1 (also known as Npn-1, NRP1, neuropilin, or CD304/BDCA4) is a 130-140 kDa type I transmembrane glycoprotein that serves as a co-receptor for class III semaphorins and heparin-binding members of the VEGF family. Neuropilin-1 is used as a marker for regulatory T (Treg) cells and may participate in COVID-19 viral infections (Coronavirus SARS-CoV-2). Browse our extensive catalog for polyclonal antibodies, monoclonal antibodies, NRP1 conjugated antibodies, and recombinant rabbit monoclonal antibodies. Validated research applications include Block/Neutralize, CyTOF-ready, ELISA, IHC, IHC-Paraffin, IHC-Frozen, IP, and Western Blot. Our Neuropilin-1 antibodies can be used in a variety of model species including Human, Mouse, Rat, and Canine. Choose the anti-NRP1 antibody best suited for your research needs by viewing the technical details, images, references, reviews and related products. Each Neuropilin-1 antibody is fully covered by our Guarantee+.

Alternate Names for Neuropilin-1 Antibodies

anti-Neuropilin-1 antibody, anti-NRP1 antibody, anti-BDCA4 antibody, anti-CD304 antigen antibody, anti-DKFZp686A03134 antibody, anti-DKFZp781F1414 antibody, anti-neuropilin 1 antibody, anti-NRPNP1 antibody, anti-transmembrane receptor antibody, anti-Vascular endothelial cell growth factor 165 receptor antibody, anti-VEGF165RCD304 antibody

24 Results for "neuropilin-1" in Primary Antibodies

List

Grid

AF566

Neuropilin-1 Antibody [Unconjugated]

(10 Reviews)

(109 Publications)

100 μg

AF566

Western blot shows 25 ng of Recombinant Mouse Neuropilin-1 (Catalog # 5994-N1), Recombinant Rat Neuropilin-1 Fc Chimera (Catalog # 566-N1) and Recombinant Human Neuropilin-1 (Catalog # 3870-N1). PVDF Membrane was probed with 0.1 µg/mL of Goat Anti-Mouse/Rat Neuropilin-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF566) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for Neuropilin-1 at approximately 150 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

Neuropilin-1 was detected in immersion fixed frozen sections of embryonic rat spinal cord (15 d.p.c.) using 5 µg/mL Goat Anti-Rat Neuropilin-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF566) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counter-stained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Frozen Tissue Sections.

Neuropilin‑1 was detected in perfusion fixed frozen sections of rat spinal cord using Goat Anti-Rat Neuropilin‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF566) at 15 µg/mL overnight at 4 °C. Tissue was stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to the dorsal horn. View our protocol for Fluorescent IHC Staining of Frozen Tissue Sections.

Neuropilin‑1 was detected in immersion fixed paraffin-embedded sections of rat brain (hippocampus) using Goat Anti-Mouse/Rat Neuropilin‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF566) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC004). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in neuronal cell bodies and projections. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Neuropilin‑1 was detected in immersion fixed paraffin-embedded sections of rat brain (thalamus) using Goat Anti-Mouse/Rat Neuropilin‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF566) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC004). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in neuronal cell bodies and projections. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Nrp1 influences Smad2/3 activation.(a–c) Representative confocal images of wt sprouts from EBs immunolabelled for pSmad2. The outline of the wt sprouts is indicated with a dashed line using the endogenous DsRED marker. DAPI staining (not shown) was used to mark nuclei (blue line). Sprouts from (a) untreated EBs, (b) treated with 2 ng ml−1 Tgf-beta for 1 h and(c) treated with 10 μM SB-421543 for 4 h. Scale bar, 13 μm. (d,e) Western blot analysis of proteins from P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h. Full western blots are shown in Supplementary Fig. 10. A representative blot of six is shown; P=0.0012 NRP1 siRNA compared with control. (f,g) Proteins from P4 HUVEC transfected with control-GFP and NRP1–GFP–His construct for 24 h, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h were assessed for SMAD2 phosphorylation. Full western blots are shown in Supplementary Fig. 11. A representative blot of four is shown; P=0.0017 NRP1 overexpression compared with control. (e,g) Quantification of pSMAD2 protein normalized to SMAD2/3. (h–k) Western blot analysis of proteins from P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h. Full western blots are shown in Supplementary Figs 12 and 13. (i) Quantification of pSMAD2 protein normalized to SMAD2/3; P=0.0848 Nrp1 siRNA compared with control. (k) Quantification of pSMAD3 protein normalized to SMAD3; P=0.0181 NRP1 siRNA compared with control. (l,m) Western blot analysis of P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 10 ng ml−1 BMP9 for 15 and 30 min. Full western blots are shown in Supplementary Fig. 14. A representative blot of four is shown. (m) Quantification of pSMAD2/3 protein normalized to SMAD2; P<0.0011 NRP1 siRNA compared with control. All values represent mean±s.e.m. DAPI, 4,6-diamidino-2-phenylindole; NS, not significant. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/26081042), licensed under a CC-BY license. Not internally tested by R&D Systems.

Expression of candidate genes. (A) qPCR analysis of relative mRNA levels in total RNA from isolated glomeruli of Foxc2fl/fl; Pod‐Cre+, Foxc2fl/+; Pod‐Cre+ and Foxc2fl/+ mice. Expression levels were normalized against the expression of Rplp0. (B) qPCR analysis of relative mRNA levels in total RNA from a podocyte cell line treated with either Foxc2 siRNA or non‐targeting siRNA. (C) Western blot analysis of NRP1 and ITGB1 protein expression after Foxc2 induction (pBABE‐Foxc2) or knockdown (Foxc2 siRNA). Empty vector (pBABE) and non‐targeting siRNA was used as controls. *P < 0.05 Foxc2fl/fl;Pod‐Cre+ versus Foxc2fl/+. Error bars in (A) and (B) represent SEM. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/31062503), licensed under a CC-BY license. Not internally tested by R&D Systems.

<b>Genetic Strategies Validation. </b>Nrp1 influences Smad2/3 activation.(a–c) Representative confocal images of wt sprouts from EBs immunolabelled for pSmad2. The outline of the wt sprouts is indicated with a dashed line using the endogenous DsRED marker. DAPI staining (not shown) was used to mark nuclei (blue line). Sprouts from (a) untreated EBs, (b) treated with 2 ng ml−1 Tgf-beta for 1 h and(c) treated with 10 μM SB-421543 for 4 h. Scale bar, 13 μm. (d,e) Western blot analysis of proteins from P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h. Full western blots are shown in Supplementary Fig. 10. A representative blot of six is shown; P=0.0012 NRP1 siRNA compared with control. (f,g) Proteins from P4 HUVEC transfected with control-GFP and NRP1–GFP–His construct for 24 h, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h were assessed for SMAD2 phosphorylation. Full western blots are shown in Supplementary Fig. 11. A representative blot of four is shown; P=0.0017 NRP1 overexpression compared with control. (e,g) Quantification of pSMAD2 protein normalized to SMAD2/3. (h–k) Western blot analysis of proteins from P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 2 ng ml−1 TGF-beta for 1 h. Full western blots are shown in Supplementary Figs 12 and 13. (i) Quantification of pSMAD2 protein normalized to SMAD2/3; P=0.0848 Nrp1 siRNA compared with control. (k) Quantification of pSMAD3 protein normalized to SMAD3; P=0.0181 NRP1 siRNA compared with control. (l,m) Western blot analysis of P4 HUVEC transfected with control siRNA and NRP1 siRNA, with or without stimulation with 10 ng ml−1 BMP9 for 15 and 30 min. Full western blots are shown in Supplementary Fig. 14. A representative blot of four is shown. (m) Quantification of pSMAD2/3 protein normalized to SMAD2; P<0.0011 NRP1 siRNA compared with control. All values represent mean±s.e.m. DAPI, 4,6-diamidino-2-phenylindole; NS, not significant. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/26081042), licensed under a CC-BY license. Not internally tested by R&D Systems.

Rescue of VEGF-A Signaling in Nrp1cyto and Nrp1fl/fl Primary EC by Full-Length NRP1 and of EC Tubulogenesis following NRP1 siRNA Knockdown with Constitutively Active ERK(A and B) Western blot analysis of Nrp1cyto EC that were transduced with the indicated adenoviral constructs, serum-starved and stimulated with 50 ng/ml VEGF-A165. Blots (A) and quantitation of ERK activation (B) show that Ad-Nrp1, but not Ad-Nrp1cyto or Ad-Nrp1PDZ, restores VEGF-A-induced VEGFR2 and ERK activation in Nrp1cyto EC (mean ± SD, n = 3, *p < 0.05).(C and D) Western blot analysis of Nrp1fl/fl EC treated with adenoviral constructs expressing CRE recombinase to inactivate NRP1 were transduced with the indicated adenoviral constructs, serum-starved and stimulated with 50 ng/ml VEGF-A165. Blots (C) and quantitation (D) show that Ad-Nrp1, but not Ad-Nrp1cyto or Ad-Nrp1PDZ, restores the activation of VEGFR2 and ERK (mean ± SD, n = 3, *p < 0.05).(E and F) HUVEC treated with control or NRP1 siRNA were treated with the indicated adenoviral vectors to compare their capacity to undergo tube formation in 3D collagen matrices after 72 hr. Representative images (E) and quantification (F) of tubulogenesis after 72 hr (mean ± SEM, n = 18, *p < 0.05). Scale bar represents 100 um. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23639442), licensed under a CC-BY license. Not internally tested by R&D Systems.

Impaired VEGF-A Signaling in Nrp1cyto Mice(A) Western blot analysis of heart lysates following intraperitoneal injection of VEGF-A. Blots show reduced ERK and VEGFR2 phosphorylation in Nrp1cyto mice relative to WT littermates.(B–D) Western blot analysis of cell lysates from primary arterial EC from Nrp1cyto and WT EC that were serum-starved and then stimulated for the indicated times with 50 ng/ml VEGF-A165. (B) Blots show reduced phosphorylation of VEGFR2 on Y1175 and of ERK in Nrp1cyto relative to control EC. (C) Quantification of the ratio of phospho-VEGFR2 (pVEGFR2) relative to total VEGFR2 (VEGFR2) (mean ± SD, n = 5, *p < 0.05). (D) Quantification of the ratio of phospho-ERK (pERK) relative to total ERK (ERK) (mean ± SD, n = 5, *p < 0.05).(E) Western blot analysis of cell lysates from Nrp1cyto and WT primary arterial EC that were serum-starved and stimulated for the indicated times with 50 ng/ml of FGF2 or IGF1. ERK phosphorylation was similar in Nrp1cyto and WT EC.See also Figure S4. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23639442), licensed under a CC-BY license. Not internally tested by R&D Systems.

Rescue of Defective ERK Signaling in VEGF-A-Stimulated Nrp1cyto Arterial EC by Knockdown of PTP1bPrimary arterial EC from Nrp1cyto mice transfected with siRNA specific for the indicated phosphatases were serum-starved and then stimulated with 50 ng/ml VEGF-A165.(A and B) Knockdown of the indicated phosphatases in Nrp1cyto arterial EC shown by immunoblotting (A); PTP1b knockdown was quantified in (B), dashed line indicates normal expression levels.(C and D) ERK and VEGFR2 (Y1175) phosphorylation after knockdown of the indicated phosphatases shown by immunoblotting (C). Quantification of pERK activation is shown in (D) (n = 3, mean ± SD, *p < 0.05). Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/23639442), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reactivity:

Mu, Rt

Species Glossary

Reactivity: Mu, Rt

Applications:

, , , ,

Applications: , , , ,

Host:

Goat Polyclonal

Host: Goat Polyclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Validated by:

Validated by:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 700	FAB566N
Allophycocyanin	FAB566A
Biotin	BAF566
Fluorescein	FAB566F
Phycoerythrin	FAB566P

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	FAB566F
Carrier Free	FAB566P
Carrier Free	FAB566A
Carrier Free	FAB566N
Carrier Free	AF566-SP

compare

(select up to 3 products from this page to compare)

AF3870

Neuropilin-1 Antibody [Unconjugated]

(22 Publications)

100 μg

AF3870

Western blot shows lysates of MDA‑MB‑231 human breast cancer cell line and human placenta tissue. PVDF membrane was probed with 1 µg/mL of Sheep Anti-Human Neuropilin‑1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3870) followed by HRP-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # HAF016). A specific band was detected for Neuropilin‑1 at approximately 130 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

HUVEC human umbilical vein endothelial cells were stained with Sheep Anti-Human Neuropilin‑1 Antigen Affinity‑purified Polyclonal Antibody (Catalog # AF3870, filled histogram) or control antibody (Catalog # 5-001-A, open histogram), followed by NorthernLights™ 637-conjugated Anti-Sheep IgG Secondary Antibody (Catalog # NL011).

Neuropilin-1 was detected in immersion fixed PC-3 human prostate cancer cell line (positive staining) and HLDM-2 human Hodgkin's lymphoma cell line (negative staining) using Sheep Anti-Human Neuropilin-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3870) at 5 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Sheep IgG Secondary Antibody (red; Catalog # NL010) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.

Neuropilin-1 was detected in immersion fixed paraffin-embedded sections of human pancreatic cancer tissue using Sheep Anti-Human Neuropilin-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3870) at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using the Anti-Sheep HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS019) and counterstained with hematoxylin (blue). Specific labeling was localized to the cytoplasm and plasma membrane of cancer cells. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

<b>Genetic Strategies Validation. </b>NRP1-dependent EGFR/ERK signalling pathways are activated by EBV and are also associated with the promotion of EBV infection.(a,b) EBV infection activated EGFR/AKT and EGFR/ERK pathways. Serum-starved HNE1 cells were infected with EBV (a) or purified EBV (b) at an MOI of 5 × 103 for the indicated times. (c) EBV-activated EGFR/AKT or EGFR/ERK pathways were partially mediated by NRP1. After transfected with the indicated siRNA duplexes for 48 h, HNE1 cells were serum-starved and infected with EBV at an MOI of 5 × 103 for 1 h, followed by western blotting. For a–c, the intensity of the bands, determined with the ImageJ software, was shown as indicated. alpha -Tubulin, internal control. (d) Schematic diagram of RTKs (EGFR and VEGFR2)/NRP1/Ras/ERK and RTKs/NRP1/PI3K/AKT signalling cascade inhibitors targeting the indicated members of the pathways are shown. (e) EGFR/Ras/ERK signalling pathway was required for EBV infection. EGF-treated HNE1 and NPEC1-Bmi1 cells pre-incubated with Gefitinib (20 μM), Sorafenib (HNE1, 20 μM; NPEC1-Bmi1, 5 μM), U0126 (50 μM) and LY294002 (50 μM) for 30 min were infected with EBV for 2 h, and then cultured in the fresh medium for 48 h until FACS analysis for the infection efficiency. (f,g) Downregulation of EGFR and c-Met impaired EBV infection. HNE1 cells were transfected with siRNA duplexes targeting EGFR or c-Met for 48 h, followed by real-time PCR analysis for the expressions of EGFR and c-Met (f) or FACS analysis for EBV infection efficiency (g). (h) HRas partially rescued the inhibitory effect of Gefitinib on EBV infection. HNE1 cells transfected with pMSCV-HRAS-V12 plasmid for 24 h were pre-incubated with 20 μM Gefitinib for 30 min, followed by exposure to EBV. (i) HRas failed to rescue the suppressive effect of silencing NRP1 on EBV infection. After transfected with siNRP1 or siControl for 36 h, HNE1 cells were reseeded, and then transfected with the plasmid for HRAS-V12 or the empty vector for 24 h, followed by exposure to EBV. The infected cells were analysed by FACS, with controls set to 100%. For (e–i), data represent three times independent experiments. Graphs show mean±s.e.m. ***P<0.001; **P<0.01; *P<0.05; Student’s t-test. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25670642), licensed under a CC-BY license. Not internally tested by R&D Systems.

<b>Genetic Strategies Validation. </b>NRP1 enhances EBV infection, while NRP2 suppresses EBV infection.(a,b) Downregulation of NRP1 impaired, whereas knockdown of NRP2 promoted EBV infection. HNE1 cells were transfected with siRNA duplexes targeting NRP1 or NRP2 for 48 h, followed by NRP expression analysis by real-time PCR (a) or analysis for the efficiency of EBV infection (b); n=3. (c) EBV infection was blocked by soluble NRP1ABC, but enhanced by antibody against NRP2. For NRP1ABC protein-blocking experiment, HNE1 cells were infected with EBV, which was pre-incubated with purified NRP1ABC for 1 h. For antibody against NRP2-blocking experiment, HNE1 cells were pre-incubated with an anti-NRP2 antibody (100 μg ml−1) or goat IgG (control) at 4 °C for 1 h and then were exposed to EBV at an MOI of 5 × 103 for 3 h at 4 °C. (d,e) Overexpression of NRP1 enhanced EBV infection, while NRP2 suppressed EBV infection. HNE1 cells were transiently transfected with the expression plasmid for NRP1, NRP2 or the empty vector (pMSCV) for 24 h, followed by analysis for the expression of NRP1 and NRP2 by western blotting (d) or were exposed to EBV (e). (f,g) EGF upregulated NRP1 expression and enhanced EBV infection. HNE1 cells cultured with 10 ng ml−1 EGF for 24 h were analysed for the expression of NRP1 and NRP2 by western blotting (f) or were exposed to EBV (g). (h,i) EGF-enhanced EBV infection was partially dependent on NRP1. After transfected with siRNA against NRP1 for 48 h, EGF-treated HNE1 and NPEC-Bmi1 cells maintained in KSF medium supplemented with EGF were analysed for NRP1 expression by western blotting (h) or were exposed to EBV (i). For (b), (c), (e), (g) and (i), HNE1 or NPEC1-Bmi1 cells were exposed to EBV at an MOI of 2.5 × 103 for 2 h at 37 °C, unless otherwise indicated. The percentage of GFP-positive infected cells was analysed by FACS 48 h post infection, with controls (empty vector-transfected cells or vehicle treated-cells) set to 100%. Data represent three to five independent experiments. Values in all graphs are means±s.e.m. ***P<0.001; **P<0.01; *P<0.05; Student’s t-test. For (d), (f) and (h), GAPDH served as an internal control. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/25670642), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reactivity:

Species Glossary

Reactivity: Hu

Applications:

, , , , ,

Applications: , , , , ,

Host:

Sheep Polyclonal

Host: Sheep Polyclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Validated by:

Validated by:

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	AF3870-SP

compare

(select up to 3 products from this page to compare)

MAB3870

Neuropilin-1 Antibody (446921) [Unconjugated]

(1 Review)

(5 Publications)

100 μg

MAB3870

Reactivity:

Species Glossary

Reactivity: Hu

Applications:

Applications: ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB3870U-100UG
Alexa Fluor 405	FAB3870V-100UG
Alexa Fluor 488	FAB3870G-100UG
Alexa Fluor 532	FAB3870X
Alexa Fluor 594	FAB3870T-100UG
Alexa Fluor 647	FAB3870R-100UG
Alexa Fluor 700	FAB3870N-100UG
Alexa Fluor 750	FAB3870S-100UG
Allophycocyanin	FAB3870A-100
Allophycocyanin	FAB3870A-025
Allophycocyanin/Cy7	FAB3870APCCY7
Biotin	FAB3870B
CoraFluor 1	FAB3870CL1
DyLight 350	FAB3870D
DyLight 405	FAB3870E
DyLight 488	FAB3870K
DyLight 550	FAB3870L
DyLight 594	FAB3870M
DyLight 650	FAB3870W
DyLight 680	FAB3870Y
DyLight 755	FAB3870Z
Fluorescein	FAB3870F-100
HRP	FAB3870H
Janelia Fluor 525	FAB3870JF525
Janelia Fluor 549	FAB3870I
Janelia Fluor 646	FAB3870J
Janelia Fluor 669	FAB3870JF669
PE/Atto594	FAB3870PEATT594
PE/Cy5.5	FAB3870PECY55
PE/Cy7	FAB3870PECY7
Phycoerythrin	FAB3870P-025
Phycoerythrin	FAB3870P-100
mFluor Violet 450 SE	FAB3870MFV450
mFluor Violet 500 SE	FAB3870MFV500
mFluor Violet 610 SE	FAB3870MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	MAB3870-SP
Carrier Free	FAB3870P-100
Carrier Free	FAB3870P-025
Carrier Free	FAB3870F-100
Carrier Free	FAB3870A-100
Carrier Free	FAB3870A-025
Carrier Free	FAB3870V-100UG
Carrier Free	FAB3870U-100UG
Carrier Free	FAB3870T-100UG
Carrier Free	FAB3870S-100UG
Carrier Free	FAB3870R-100UG
Carrier Free	FAB3870G-100UG
Carrier Free	FAB3870N-100UG

compare

(select up to 3 products from this page to compare)

NBP2-24617

Neuropilin-1 Antibody

0.1 mg

NBP2-24617

Reactivity:

Hu, Mu, Rt

Species Glossary

Reactivity: Hu, Mu, Rt

Applications:

Applications:

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Alt Catalog#

IMG-6360A

Alt Catalog# IMG-6360A

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

NBP2-67539

Neuropilin-1 Antibody (ST05-30)

(2 Publications)

100 ul

NBP2-67539

Immunohistochemistry-Paraffin: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Analysis of paraffin-embedded mouse kidney tissue using Neuropilin-1 antibody (ST05-30) [NBP2-67539]. Counter stained with hematoxylin.

Flow Cytometry: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Analysis of Hela cells with Neuropilin-1 antibody (ST05-30) [NBP2-67539] at 1/50 dilution (red) compared with an unlabelled control (cells without incubation with primary antibody; black). Alexa Fluor 488-conjugated goat anti rabbit IgG was used as the secondary antibody.

Immunocytochemistry/Immunofluorescence: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Staining Neuropilin-1 in HUVEC cells (green) using Neuropilin-1 antibody (ST05-30) [NBP2-67539]. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.

Immunocytochemistry/Immunofluorescence: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Staining Neuropilin-1 in SHG-44 cells (green) using Neuropilin-1 antibody (ST05-30) [NBP2-67539]. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.

Immunohistochemistry-Paraffin: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Analysis of paraffin-embedded human kidney tissue using Neuropilin-1 antibody (ST05-30) [NBP2-67539]. Counter stained with hematoxylin.

Immunohistochemistry-Paraffin: Neuropilin-1 Antibody (ST05-30) [NBP2-67539] - Analysis of paraffin-embedded human liver tissue using Neuropilin-1 antibody (ST05-30) [NBP2-67539]. Counter stained with hematoxylin.

Reactivity:

Hu, Mu, Rt

Species Glossary

Reactivity: Hu, Mu, Rt

Applications:

, , , ,

Applications: , , , ,

Host:

Rabbit Monoclonal

Host: Rabbit Monoclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

MAB59941

Neuropilin-1 Antibody (761704)

(5 Publications)

100 μg

MAB59941

Mouse splenocytes were stained with Rat Anti-Mouse CD4 APC-conjugated Monoclonal Antibody (Catalog # FAB554A) and either (A) Rat Anti-Mouse Neuropilin‑1 Monoclonal Antibody (Catalog # MAB59941) or (B) Rat IgG2A Isotype Control (Catalog # MAB006) followed by Phycoerythrin-conjugated Anti-Rat IgG Secondary Antibody (Catalog # F0105B).

Reactivity:

Species Glossary

Reactivity: Mu

Applications:

, ,

Applications: , ,

Host:

Rat Monoclonal

Host: Rat Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB59941U-100UG
Alexa Fluor 405	FAB59941V-100UG
Alexa Fluor 488	FAB59941G-100UG
Alexa Fluor 532	FAB59941X
Alexa Fluor 594	FAB59941T-100UG
Alexa Fluor 647	FAB59941R-100UG
Alexa Fluor 700	FAB59941N-100UG
Alexa Fluor 750	FAB59941S-100UG
Allophycocyanin	FAB59941A
Allophycocyanin/Cy7	FAB59941APCCY7
Biotin	FAB59941B
CoraFluor 1	FAB59941CL1
DyLight 350	FAB59941D
DyLight 405	FAB59941E
DyLight 488	FAB59941K
DyLight 550	FAB59941L
DyLight 594	FAB59941M
DyLight 650	FAB59941W
DyLight 680	FAB59941Y
DyLight 755	FAB59941Z
FITC	FAB59941F
HRP	FAB59941H
Janelia Fluor 525	FAB59941JF525
Janelia Fluor 549	FAB59941I
Janelia Fluor 646	FAB59941J
Janelia Fluor 669	FAB59941JF669
PE	FAB59941P
PE/Atto594	FAB59941PEATT594
PE/Cy5.5	FAB59941PECY55
PE/Cy7	FAB59941PECY7
PerCP	FAB59941C
mFluor Violet 450 SE	FAB59941MFV450
mFluor Violet 500 SE	FAB59941MFV500
mFluor Violet 610 SE	FAB59941MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	MAB59941-SP
Carrier Free	FAB59941G-100UG
Carrier Free	FAB59941V-100UG
Carrier Free	FAB59941U-100UG
Carrier Free	FAB59941T-100UG
Carrier Free	FAB59941S-100UG
Carrier Free	FAB59941N-100UG
Carrier Free	FAB59941R-100UG

compare

(select up to 3 products from this page to compare)

MAB5661

Neuropilin-1 Antibody (130604)

(3 Publications)

500 μg

Reactivity:

Species Glossary

Reactivity: Rt

Applications:

Applications: ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB5661U
Alexa Fluor 405	FAB5661V-100UG
Alexa Fluor 488	FAB5661G-100UG
Alexa Fluor 532	FAB5661X
Alexa Fluor 594	FAB5661T
Alexa Fluor 647	FAB5661R-100UG
Alexa Fluor 700	FAB5661N-100UG
Alexa Fluor 750	FAB5661S-100UG
Allophycocyanin	FAB5661A
Biotin	FAB5661B
DyLight 350	FAB5661D
DyLight 405	FAB5661E
DyLight 488	FAB5661K
DyLight 550	FAB5661L
DyLight 594	FAB5661M
DyLight 650	FAB5661W
DyLight 680	FAB5661Y
DyLight 755	FAB5661Z
FITC	FAB5661F
HRP	FAB5661H
Janelia Fluor 525	FAB5661JF525
Janelia Fluor 549	FAB5661I
Janelia Fluor 646	FAB5661J
Janelia Fluor 669	FAB5661JF669
PE	FAB5661P
PerCP	FAB5661C

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	MAB5661-SP
Carrier Free	FAB5661V-100UG
Carrier Free	FAB5661S-100UG
Carrier Free	FAB5661R-100UG
Carrier Free	FAB5661N-100UG
Carrier Free	FAB5661G-100UG

compare

(select up to 3 products from this page to compare)

MAB38701

Neuropilin-1 Antibody (446915)

(4 Publications)

100 μg

Reactivity:

Species Glossary

Reactivity: Hu

Applications:

Applications:

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	MAB38701-SP

compare

(select up to 3 products from this page to compare)

DDX0440P-100

Neuropilin-1 Antibody (211H6.01)

(1 Publication)

0.1 mg

DDX0440P-100

Flow Cytometry: Neuropilin-1 Antibody (211H6.01) [DDX0440P-100] - FACS analysis of human PBMC using Neuropilin-1 antibody (211H6.01) [DDX0440P-100].

Flow Cytometry: Neuropilin-1 Antibody (211H6.01) [DDX0440P-100] - FACS analysis of human monocyte-derived DC using Neuropilin-1 antibody (211H6.01) [DDX0440P-100].

Reactivity:

Hu, Ca

Species Glossary

Reactivity: Hu, Ca

Applications:

, , ,

Applications: , , ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 488	DDX0440A488-100
Alexa Fluor 546	DDX0440A546-100
Alexa Fluor 647	DDX0440A647-100
Biotin	DDX0440B-100

compare

(select up to 3 products from this page to compare)

MAB566

Neuropilin-1 Antibody (130603)

(3 Publications)

500 μg

Reactivity:

Species Glossary

Reactivity: Rt

Applications:

, ,

Applications: , ,

Host:

Mouse Monoclonal

Host: Mouse Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB566U-100UG
Alexa Fluor 405	FAB566V
Alexa Fluor 488	FAB566G
Alexa Fluor 532	FAB566X
Alexa Fluor 594	FAB566T-100UG
Alexa Fluor 647	FAB566R
Alexa Fluor 750	FAB566S
Allophycocyanin/Cy7	FAB566APCCY7
Biotin	FAB566B
DyLight 350	FAB566D
DyLight 405	FAB566E
DyLight 488	FAB566K
DyLight 550	FAB566L
DyLight 594	FAB566M
DyLight 650	FAB566W
DyLight 680	FAB566Y
DyLight 755	FAB566Z
HRP	FAB566H
Janelia Fluor 525	FAB566JF525
Janelia Fluor 549	FAB566I
Janelia Fluor 646	FAB566J
Janelia Fluor 669	FAB566JF669
PE/Atto594	FAB566PEATT594
PE/Cy5.5	FAB566PECY55
PE/Cy7	FAB566PECY7

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	MAB566-SP
Carrier Free	FAB566U-100UG
Carrier Free	FAB566T-100UG

compare

(select up to 3 products from this page to compare)

MAB5994

Neuropilin-1 Antibody (761705)

(2 Publications)

100 μg

MAB5994

Reactivity:

Species Glossary

Reactivity: Mu

Applications:

Applications: ,

Host:

Rat Monoclonal

Host: Rat Monoclonal

Sizes:

Sample Size Available

Sizes: Sample Size Available

Conjugate:

Unconjugated

Available Conjugates:

Conjugate	Catalog #	Availability	Size	Price
Alexa Fluor 350	FAB5994U-100UG
Alexa Fluor 405	FAB5994V-100UG
Alexa Fluor 488	FAB5994G-100UG
Alexa Fluor 532	FAB5994X
Alexa Fluor 594	FAB5994T-100UG
Alexa Fluor 700	FAB5994N-100UG
Alexa Fluor 750	FAB5994S-100UG
Allophycocyanin	FAB5994A
Allophycocyanin/Cy7	FAB5994APCCY7
Biotin	FAB5994B
CoraFluor 1	FAB5994CL1
DyLight 350	FAB5994D
DyLight 405	FAB5994E
DyLight 488	FAB5994K
DyLight 550	FAB5994L
DyLight 594	FAB5994M
DyLight 650	FAB5994W
DyLight 680	FAB5994Y
DyLight 755	FAB5994Z
FITC	FAB5994F
HRP	FAB5994H
Janelia Fluor 525	FAB5994JF525
Janelia Fluor 549	FAB5994I
Janelia Fluor 646	FAB5994J
Janelia Fluor 669	FAB5994JF669
PE/Atto594	FAB5994PEATT594
PE/Cy5.5	FAB5994PECY55
PE/Cy7	FAB5994PECY7
PerCP	FAB5994C
Phycoerythrin	FAB5994P
mFluor Violet 450 SE	FAB5994MFV450
mFluor Violet 500 SE	FAB5994MFV500
mFluor Violet 610 SE	FAB5994MFV610

Available Formulations

Formulation	Catalog #	Availability	Price
Carrier Free	FAB5994N-100UG
Carrier Free	FAB5994A
Carrier Free	FAB5994P
Carrier Free	MAB5994-SP
Carrier Free	FAB5994V-100UG
Carrier Free	FAB5994U-100UG
Carrier Free	FAB5994T-100UG
Carrier Free	FAB5994S-100UG
Carrier Free	FAB5994G-100UG

compare

(select up to 3 products from this page to compare)

NBP3-23182

Neuropilin-1 Antibody

0.1 ml

NBP3-23182

Reactivity:

Hu, Mu, Rt

Species Glossary

Reactivity: Hu, Mu, Rt

Applications:

, ,

Applications: , ,

Host:

Rabbit Polyclonal

Host: Rabbit Polyclonal

Conjugate:

Unconjugated

compare

(select up to 3 products from this page to compare)

page of 2

At	=	A. thaliana	SyHa	=	Golden Syrian Hamster
All	=	All Species	Ha	=	Hamster
An	=	Animal	Hu	=	Human
ArHa	=	Armenian Hamster	I	=	Insect
Av	=	Avian	Ll	=	Llama
Bb	=	Baboon	Ma	=	Mammal
Ba	=	Bacteria	Mk	=	Monkey
Bv	=	Bovine	Mu	=	Mouse
Ca	=	Canine	Multi	=	Multi-species
Ce	=	C. Elegans	NA	=	Non-species specific
Ch	=	Chicken	Or	=	Orangutan
ChHa	=	Chinese Hamster	Pl	=	Plant
Cm	=	Cynomolgus Monkey	Pm	=	Primate
Do	=	Donkey	Po	=	Porcine
Dr	=	Drosophilia	Rb	=	Rabbit
Ec	=	E. Coli	Rt	=	Rat
Eq	=	Equine	RM	=	Rhesus Macaque
Fe	=	Feline	Sh	=	Sheep
Ft	=	Ferret	Vb	=	Vertebrate
Fi	=	Fish	Vi	=	Virus
Fu	=	Fungi	Xp	=	Xenopus
Ge	=	Gerbil	Ye	=	Yeast
GP	=	Guinea Pig	Ze	=	Zebrafish
Gt	=	Goat

Category

Protein/Target

Applications

Reactivity

Citation

Reviews

Host

Available Conjugates

Modification

Clonality

Clone

Images Type

Isotype

Preservative

Research Areas

Has Sample Size

Promotional Item

Species Glossary

Neuropilin-1 Antibodies

Neuropilin-1 Antibody [Unconjugated]

Neuropilin-1 Antibody [Unconjugated]

Neuropilin-1 Antibody (446921) [Unconjugated]

Neuropilin-1 Antibody

Neuropilin-1 Antibody (ST05-30)

Neuropilin-1 Antibody (761704)

Neuropilin-1 Antibody (130604)

Neuropilin-1 Antibody (446915)

Neuropilin-1 Antibody (211H6.01)

Neuropilin-1 Antibody (130603)

Neuropilin-1 Antibody (761705)

Neuropilin-1 Antibody